Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study.
about
Occupancy of dopamine D₂ and D₃ and serotonin 5-HT₁A receptors by the novel antipsychotic drug candidate, cariprazine (RGH-188), in monkey brain measured using positron emission tomographyAnimal models of schizophrenia: a critical reviewChange of dopamine receptor mRNA expression in lymphocyte of schizophrenic patientsRecent methods for measuring dopamine D3 receptor occupancy in vivo: importance for drug developmentSchizophrenia and the cannabinoid receptor type 1 (CB1): association study using a single-base polymorphism in coding exon 1Blinded prospective evaluation of computer-based mechanistic schizophrenia disease model for predicting drug responseSelective overexpression of dopamine D3 receptors in the striatum disrupts motivation but not cognition.Using prepulse inhibition to detect functional D3 receptor antagonism: effects of WC10 and WC44Epilepsy, schizophrenia, and the extended amygdala.Mesolimbic activity associated with psychosis in schizophrenia. Symptom-specific PET studies.D3 receptors and the actions of neuroleptics in the ventral striatopallidal system of schizophrenics.Dopamine and psychosis: theory, pathomechanisms and intermediate phenotypesBDNF controls dopamine D3 receptor expression and triggers behavioural sensitization.Design, synthesis, and structure-activity relationship studies of a series of [4-(4-carboxamidobutyl)]-1-arylpiperazines: insights into structural features contributing to dopamine D3 versus D2 receptor subtype selectivity.Blockade of dopamine D₃ but not D₂ receptors reverses the novel object discrimination impairment produced by post-weaning social isolation: implications for schizophrenia and its treatment.Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs.G protein-coupled receptors in major psychiatric disorders.Investigational drugs for schizophrenia targeting the dopamine receptor: phase II trials.Targeting the dopamine receptor in schizophrenia: investigational drugs in Phase III trials.Neural models of schizophreniaFronto-limbic novelty processing in acute psychosis: disrupted relationship with memory performance and potential implications for delusions.Dopamine and glutamate dysfunctions in schizophrenia: role of the dopamine D3 receptor.Multifaceted genomic risk for brain function in schizophrenia.Molecular characterization of individual D3 dopamine receptor-expressing cells isolated from multiple brain regions of a novel mouse modelThe mRNA Expression Status of Dopamine Receptor D2, Dopamine Receptor D3 and DARPP-32 in T Lymphocytes of Patients with Early PsychosisAberrant dopamine D2-like receptor function in a rodent model of schizophrenia.The pipeline and future of drug development in schizophrenia.Dopamine hypothesis of schizophrenia: making sense of it all.Evaluation of N-phenyl homopiperazine analogs as potential dopamine D3 receptor selective ligands.The potential role of dopamine D₃ receptor neurotransmission in cognition.Genetic underpinnings of tardive dyskinesia: passing the baton to pharmacogenetics.Absorbed radiation dosimetry of the D3-specific PET radioligand [18F]FluorTriopride estimated using rodent and nonhuman primate.The biochemical womb of schizophrenia: A review.Dopamine D3 receptor antagonists: a patent review (2007 - 2012).Pharmacogenetics of clinical response to risperidone.Current Concepts on the Physiopathological Relevance of Dopaminergic ReceptorsEffect of dopamine D3 receptor gene polymorphisms and clozapine treatment response: exploratory analysis of nine polymorphisms and meta-analysis of the Ser9Gly variant.The dopamine D2 receptors in high-affinity state and D3 receptors in schizophrenia: a clinical [11C]-(+)-PHNO PET study.Dopamine D3 Receptors Inhibit Hippocampal Gamma Oscillations by Disturbing CA3 Pyramidal Cell Firing Synchrony.Buspirone Counteracts MK-801-Induced Schizophrenia-Like Phenotypes through Dopamine D3 Receptor Blockade.
P2860
Q24630426-03AF9575-600F-469D-835A-01623BDE9974Q24674909-693BDDA5-EF0A-4D40-93D7-7C5F1697C9ECQ24796172-33631E6F-4B84-43D4-988C-5B8563CA1DD4Q27014737-0A1E88FB-7418-4DDD-A72C-210CB18A2500Q28216128-ADD2A81A-28B3-4586-B44A-C7496C2CF1D0Q28484377-BAA6463E-1253-4178-8A34-9011BFF7F0BEQ30423688-26B25AF3-1E8D-4C4C-B3DE-03CDFA341FB0Q30480298-34F6EA6F-BE65-4782-8200-239E362EEF6BQ33692855-412C2B68-F450-4751-9412-292EBCE9F8E2Q33692860-FC0B9FC8-6B6C-4A3E-A156-9A4EE006790AQ33692872-6DE15AE6-A786-47EC-8411-CF7F1E011498Q33729433-37D795FB-C8EE-4C6E-86F3-ECDDD767A5B5Q33945215-0C3C60A3-CB92-46B6-B403-3BFF810ED0AEQ34104379-823FD283-DD03-4B6B-A1B1-91B66E758970Q34171445-8AD3A328-EFF2-495E-8F7C-4509B46D5696Q34338202-77DA17AD-FD0A-44CD-BB96-C37F8E46AB08Q34578414-23763AE4-A3D2-4A23-9606-7550DA4B53A1Q34703195-63FF2B94-1AE5-40D2-95CB-08A9EFD3FD59Q35071909-3127E10F-AB01-4AF0-AE06-47DA9925F682Q35236271-9CBF9E1C-C124-4E62-969F-3FA47C6C1DD6Q35668695-AAFE5CF9-5F48-4405-8153-7CE576E492E3Q35796578-B390D41E-57C5-4D92-B0C3-95EBF631EC4BQ36035361-F18EB35C-E0B8-4F83-A7FB-B9B1BEBA46FDQ36137258-3CDD7767-8DFC-448C-B9D2-352EE6920993Q36324583-21E6CD18-9D51-4D45-8F13-E62AE17488D5Q36335503-9E9D9344-35FE-4FDB-B5CB-8F8E3FB3A1DFQ36898681-FCF539A7-CC8C-4EAC-8B3C-BEC4840EFBD1Q36946141-40FDCE71-59FA-42B2-8ABC-DAC61F41C8CEQ37070133-FF26011F-C079-4510-939E-AF7BC2DE54A8Q37106827-D5AEE9B2-F2A4-4E9D-A52B-C555EB4FF0B3Q37264543-FB885DAC-93FD-4E76-B525-8F064C6D42DCQ37568555-0C789BE3-BF3B-4E2C-AB1A-398A83ACAFA0Q38056122-AD746C8E-626C-42AE-99CE-F48D474A0E38Q38071135-82A20958-C38B-4478-B2C6-2B55555933CAQ38074712-D6BBE9A1-84AB-4E03-A60F-066B3F6CB3BAQ39147170-DD0CA798-F565-424F-8A81-62C931BEB031Q39916831-860AC6AA-8C84-4FAF-A306-244706F13BF6Q40029733-D102AC65-9877-4BBC-8A60-CB09433A4BC8Q41954081-7888462A-A1EB-4C91-A452-735CB226A142Q42372881-EE02ED2E-4242-43B4-BC30-363A380E6425
P2860
Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Mesolimbic dopamine D3 recepto ...... zophrenia. A postmortem study.
@en
Mesolimbic dopamine D3 recepto ...... zophrenia. A postmortem study.
@nl
type
label
Mesolimbic dopamine D3 recepto ...... zophrenia. A postmortem study.
@en
Mesolimbic dopamine D3 recepto ...... zophrenia. A postmortem study.
@nl
prefLabel
Mesolimbic dopamine D3 recepto ...... zophrenia. A postmortem study.
@en
Mesolimbic dopamine D3 recepto ...... zophrenia. A postmortem study.
@nl
P2093
P921
P1433
P1476
Mesolimbic dopamine D3 recepto ...... zophrenia. A postmortem study.
@en
P2093
P304
P356
10.1001/ARCHPSYC.1997.01830150047009
P407
P577
1997-03-01T00:00:00Z